Author

N. Sethi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

L. Vizkeleti· 2 shared S. Spisak· 2 shared A. Prosz· 1 shared B. Wolpin· 1 shared D. Chen· 1 shared D. R. Stormoen· 1 shared G. T.Klus· 1 shared H. Duan· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Vizkeleti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer

S. Spisak, D. Chen, P. Likasitwatanakul, P. Doan, Z. Li, P. Bala, L. Vizkeleti, P. De Silva, M. Giannakis, B. Wolpin, J. Qi, N. Sethi

bioRxiv · Jun 21, 2023 · PreprintCancer Biology

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

A. Prosz, H. Duan, V. Tisza, P. Sahgal, S. Topka, G. T.Klus, J. Borscok, Z. Sztupinszki, T. Hanlon, M. Diossy, L. Vizkeleti, D. R. Stormoen, I. Csabai, H. Pappot, J. Vijai, , Z. Szallasi

This paper identifies NER deficiency as a targetable vulnerability in ccRCC, showing that 10% of patients may respond to irofulven based on mutational signatures and PTGR1 expression.

bioRxiv · Feb 7, 2023Cancer Biology